SynthesisJournal of neuro-oncology2026

Cerebrospinal fluid ctDNA as a prognostic and disease-activity biomarker in leptomeningeal metastases: systematic review, meta-analysis, and implications for CSF-guided care.

Baradwaj Simha Sankar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.